Skip to main content
. 2010 Jul 1;118(8):2069–2076. doi: 10.1182/blood-2011-01-330563

Table 4.

Categorization of overall responses based on the EUMNET and IWG-MRT criteria

Intention to treat (n = 30) Per-protocol (n = 25)
EUMNET criteria
    Complete response 0 (0.0) 0 (0.0)
    Major response 8 (26.7) 8 (32.0)
    Moderate response 7 (23.3) 5 (20.0)
    Minor response 3 (10.0) 2 (8.0)
    No response 12 (40.0) 10 (40.0)
    Progression 0 (0.0) 0 (0.0)
IWG-MRT criteria
    Complete response 0 (0.0) 0 (0.0)
    Partial remission 1 (3.3) 1 (4.0)
    Clinical improvement 6 (20.0) 5 (20.0)
    Progressive disease 0 (0.0) 0 (0.0)
    Stable disease 23 (76.7) 19 (76.0)
    Relapse 0 (0.0) 0 (0.0)

EUMNET indicates European Network for Myelofibrosis; and IWG-MRT, International Working Group for Myelofibrosis Research and Treatment.